NPPB and pulmonary arterial hypertension: NT-proBNP is another non-invasive, sensitive measure of RV function and has been shown to be prognostic in PAH [28–30], although it is not specific to the disease and its potential to be used as a surrogate end-point for long-term outcomes in PAH has yet to be validated [31].